INTERVENTIONAL TRIALS
Before participating in a trial, talk to your health care provider and learn about the risks and potential benefits.
RECRUITING
This study aims to see if a single dose of the drug ALN-HTT02 is safe, how well people can handle it, and how the body responds to and processes the drug.
A small, first-time study looking for early signs of Huntington’s disease in people who carry the gene but don’t have symptoms yet.
Researchers would like to find out which approach is better for improving people’s health and well-being: doing physical and mental exercises together, or doing them separately in sequence.
Researchers want to see if a new, longer-lasting brain scan can replace the old one and help doctors follow how Huntington’s disease progresses and how well treatments are working.
This study is testing a new experimental medicine called SKY-0515 to see if it can help people who have HD
This study looks at whether using DoddleBags can make eating easier and more manageable for people with Huntington’s disease. Everyone in the study will use a DoddleBag during mealtimes, and we will explore whether it helps them feed themselves more easily and independently, and whether they find it practical and acceptable to use.
This study will check if taking thiamine and biotin together as a pill is safe and easy for people with mild to moderate Huntington’s disease to take.
The study is testing a new way to “see” and track Huntington’s disease in the brain, which could help improve diagnosis and future treatments.
A study that takes repeated brain scans over time to see how certain brain areas change in people who carry the Huntington’s disease gene but don’t yet have symptoms.
A study testing whether music therapy can help reduce irritability and impulsive behavior in people with Huntington’s disease.
A study testing whether Nicotinamide Riboside is safe and can help improve symptoms in people with Huntington’s disease, compared to a dummy treatment (placebo).
A study testing whether the drug VO659 is safe and how the body processes it in people with SCA1, SCA3, and Huntington’s disease.
NOT YET RECRUITING IN EUROPE
The trial will test how well Votoplam works and the safety in a larger group of participants
A study testing whether the drug RG6496 is safe and how the body processes it in people with HD
ACTIVE, NOT RECRUITING
A study testing a treatment called AB-1001, which is given directly to a specific brain area, in adults who have just started showing symptoms of Huntington’s disease.
A study testing whether the drug Tominersen is safe, how it affects certain disease markers, and whether it helps people with early or very early Huntington’s disease, compared to a dummy treatment (placebo).
A study testing whether the treatment AMT-130 is safe and helpful for adults in Europe who have just started showing symptoms of Huntington’s disease.
